Cargando…

Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer

OBJECTIVE: Using whole genome sequencing, we identified gene amplification of solute carrier family 12 member 5 (SLC12A5) located at 20q13.12 in colorectal cancer (CRC). We analysed its amplification, overexpression, biological effects and prognostic significance in CRC. DESIGN: SLC12A5 amplificatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lixia, Li, Xiaoxing, Cai, Muyan, Chen, Jinna, Li, Xiangchun, Wu, William K K, Kang, Wei, Tong, Joanna, To, Ka-Fai, Guan, Xin-Yuan, Sung, Joseph J Y, Chan, Francis K L, Yu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Colon
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819609/ https://www.ncbi.nlm.nih.gov/pubmed/25947013 http://dx.doi.org/10.1136/gutjnl-2014-308257

Ejemplares similares

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
por: Yu, Jun, et al.
Publicado: (2015)

Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axis
por: Zhang, Jingwan, et al.
Publicado: (2016)

Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
por: Li, Chuangen, et al.
Publicado: (2022)

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
por: Amicarella, F, et al.
Publicado: (2017)

Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
por: Bao, Yi, et al.
Publicado: (2023)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
por: Møller, Pål, et al.
Publicado: (2017)

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)
por: Salvucci, Manuela, et al.
Publicado: (2022)

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
por: Møller, Pål, et al.
Publicado: (2018)

Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer
por: Betts, Gareth, et al.
Publicado: (2011)

Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)
por: Puthia, Manoj, et al.
Publicado: (2014)

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
por: Ferrer-Mayorga, Gemma, et al.
Publicado: (2017)

Randomised clinical study comparing the effectiveness and physiological effects of hypertonic and isotonic polyethylene glycol solutions for bowel cleansing
por: Yamano, Hiro-o, et al.
Publicado: (2016)

Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines
por: Davis, Hayley, et al.
Publicado: (2014)

Low-residue breakfast during the preparation for colonoscopy using a polyethylene glycol electrolyte solution: a randomised non-inferiority trial
por: Flemming, Jennifer A, et al.
Publicado: (2015)

Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor
por: Yeoh, Yun Kit, et al.
Publicado: (2020)

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017)

Initial US evaluation of second-generation capsule colonoscopy for detecting colon polyps
por: Morgan, Douglas R, et al.
Publicado: (2016)

Does Hispanic ethnicity play a role in outcomes for diverticular surgery in the USA?
por: Kelley, Jesse K, et al.
Publicado: (2023)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Source of dietary fibre and diverticular disease incidence: a prospective study of UK women
por: Crowe, Francesca L, et al.
Publicado: (2014)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population
por: Cui, R, et al.
Publicado: (2011)

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres
por: Jones, A M, et al.
Publicado: (2011)

Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
por: Peng, Szu-Min, et al.
Publicado: (2021)

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
por: Sullivan, Kevin M, et al.
Publicado: (2023)

Novel TCF21(high) pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix
por: Li, Xiaobo, et al.
Publicado: (2023)

Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis
por: Li, Jingyun, et al.
Publicado: (2020)

Genomic evolution and diverse models of systemic metastases in colorectal cancer
por: Chen, Hai-Ning, et al.
Publicado: (2022)

Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program
por: Chiu, Sherry Yueh-Hsia, et al.
Publicado: (2017)

Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
por: Chiu, Han-Mo, et al.
Publicado: (2021)

Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer
por: Montazeri, Zahra, et al.
Publicado: (2020)

Genetic architectures of proximal and distal colorectal cancer are partly distinct
por: Huyghe, Jeroen R, et al.
Publicado: (2021)

Performance measures in three rounds of the English bowel cancer screening pilot
por: Moss, S M, et al.
Publicado: (2011)

Colorectal cancer screening with odour material by canine scent detection
por: Sonoda, Hideto, et al.
Publicado: (2011)

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction
por: Tian, Sun, et al.
Publicado: (2013)

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models
por: Hackl, Christina, et al.
Publicado: (2013)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer
por: Ji, Shunlong, et al.
Publicado: (2013)

Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation
por: Lourenço, Filipe C, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r0g4ua87mkbktj5kt3lv0mvbr4